Evidence map›Paper›PMID 35893610›Full record

ArticlePlants (Basel, Switzerland)2022

Alkaloid Composition and Biological Activities of the Amaryllidaceae Species

Marilú Roxana Soto-Vásquez, Cecilia Anataly Rodríguez-Muñoz, Luciana R Tallini, Jaume Bastida

Abstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. The Occurrence and Bioactivities ofPlants (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Antileishmanial Activity ofPlants (Basel, Switzerland) · 2023
    Article
  8. Chemical Survey of Three Species of the GenusPlants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marilú Roxana Soto-VásquezFacultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Av. Juan Pablo II, Trujillo 13011, Peru.ORCID 0000-0002-1178-4678
Cecilia Anataly Rodríguez-MuñozFacultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Av. Juan Pablo II, Trujillo 13011, Peru.
Luciana R TalliniPrograma de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, Porto Alegre 90610-000, RS, Brazil.
Jaume BastidaDepartament de Biologia, Sanitat i Medi Ambient, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Av. Joan XXIII #27-31, 08028 Barcelona, Spain.

Funding

CAPES (Coordenação de Pessoal de Nível Superior) Processo 13553135Conselho Nacional de Desenvolvimento Científico e Tecnológico Grant # 380791/2022-6Fondo Nacional de Desarrollo Cientifico, Tecnológico y de Innovacion Tecnologica (FONDECYT) del Consejo Nacional de Ciencia Tecnologia e Innovacion Tecnologica (CONCYTEC- Peru) Grant N. 110 -2018 - FONDECYTPrograma Iberoamericano de Ciencia y Tecnología para el Desarrollo CYTED 416RT0511
6 · The paper itself

Abstract

Natural products have always played a significant role in the search for new drugs. One of the most relevant alkaloid-containing plant groups is the Amaryllidaceae family, a source of exclusive structures with a wide variety of pharmacological activities. The aim of this work was to determine the alkaloid composition and biological potential of an extract from the bulbs of an endemic Peruvian Amaryllidaceae species

Indexed as

alkaloidsAlzheimer’s diseaseAmaryllidaceaeIsmene amancaesmalariaPlasmodium falciparum

Identifiers

PMID35893610
PMCPMC9331871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.